Two of the most powerful longevity tools I use point at the exact same target inside your cells. Most people have heard of one of them. Fewer have heard of the other. Almost no one understands why I use them together, or why the combination, done correctly, does more than either does on its own.

‍

Your body runs in two modes

‍

Every cell you have is always doing one of two things. Building or cleaning. When you eat, insulin and a related signal called IGF-1 rise and switch on a master growth pathway called mTOR. mTOR is not the enemy. It builds muscle and tissue and drives the machinery of being alive. The problem is that it was never meant to run all day, every day, and in a modern life of constant eating, it does exactly that.

‍

The other mode is cleanup. When food is absent and insulin falls, an energy sensor called AMPK comes online, a family of repair enzymes called sirtuins that run on a molecule called NAD+ ramps up, and the cell switches on autophagy, its recycling program. Autophagy means self-eating. The cell finds its own broken parts, the damaged proteins and the worn out mitochondria, and breaks them down for parts. mTOR is the master switch for the building side. Quiet it, and the cleanup crew goes to work.

‍

Health is the ability to move efficiently between these two modes. The people who age badly are almost always stuck on the same side: insulin always up, mTOR always on, the cleanup crew never called. Both fasting and rapamycin are ways to force the switch into cleanup. They just do it differently.

‍

Fasting, the physiological switch

‍

Fasting is the body's own way of flipping into cleanup. Give it a long enough gap without food and a cascade begins. Liver glycogen runs down, insulin drops, the body burns fat and makes ketones, AMPK rises, NAD+ rises and wakes the sirtuins, mTOR goes quiet, and autophagy switches on. This is not a hack and it is not a trend. Every animal on earth evolved with gaps between meals. The fasted state is a maintenance cycle your cells are built to run, and one almost no one runs anymore.

‍

A 2024 study in Nature followed 960 genetically diverse mice and confirmed that both fasting and calorie restriction extended lifespan in proportion to the degree of restriction. But the detail that mattered most was this - the leanest animals did not live the longest. The strongest predictor of a long life was stress resilience, the ability to hold body weight steady through hard times, paired with a younger and less inflammatory immune profile. The most aggressive restriction extended lifespan on average but cost lean mass and weakened the immune system. The lesson is one I build my practice around: the benefit of fasting is the cellular signal, not the weight you lose. Push it too far and you strip the muscle and resilience that keep you alive.

‍

Rapamycin, the pharmacological switch

‍

Rapamycin is where this gets interesting. It is an FDA-approved drug that has been used for decades at high daily doses to prevent organ transplant rejection. At those doses it suppresses the immune system. But at a low dose taken once a week, it does something very different. It inhibits mTOR directly. In effect, it chemically convinces the cell that it is fasting, even when you have eaten. Autophagy ramps up. The body shifts from growth toward maintenance. It is the closest thing we have to a fasting signal in a capsule.

‍

The dosing schedule is the whole point, and it is where most people get it wrong. mTOR exists in two forms, mTORC1 and mTORC2. mTORC1 is the longevity target. mTORC2 governs blood sugar and insulin signaling, and you do not want to shut it down. Weekly pulsed dosing inhibits mTORC1 while letting mTORC2 recover between doses. That is why transplant patients on daily high-dose rapamycin develop insulin resistance, and why longevity patients on a low weekly pulse generally do not. Same drug, completely different effect, decided entirely by dose and timing.

‍

The human evidence is early and not definitive. An older study showed that low-dose mTOR inhibition improved the immune response to vaccination in elderly adults, partly reversing immune aging. The PEARL trial, the first long randomized placebo-controlled trial of weekly rapamycin for longevity in healthy adults, published in 2025, found that the drug was safe over a year. Its primary goal, a reduction in visceral fat, was not met. But it did show gains in lean muscle mass and reductions in pain, most clearly in women at the higher dose. What PEARL did not do is prove that rapamycin extends human lifespan. That question is still open, and anyone who tells you it is settled is ahead of the data. 

‍

Why I use them together

‍

Here is the obvious objection. If fasting and rapamycin both inhibit mTOR, is using both just redundant? It is a fair question, and the answer is no, for two reasons.

‍

First, fasting does far more than inhibit mTOR. It raises AMPK, lifts NAD+ and the sirtuins, drops insulin, and shifts you into burning fat and making ketones. Rapamycin touches none of that. It is a precision instrument aimed at one pathway. Fasting is the broad metabolic reset. Rapamycin is the deep, targeted cleanup pulse. They cover different ground.

‍

Second, most people cannot fast hard enough, long enough, or often enough to drive mTOR as low as a weekly dose of rapamycin reliably does, not while holding a job, training, and living a real life. Rapamycin delivers a deep, scheduled mTOR pulse that does not depend on willpower or a three day fast. Fasting handles the metabolic and AMPK and NAD+ arm. Rapamycin provides the deep autophagy pulse. Together they cover the cleanup side far more completely than either alone.

‍

There is also a timing logic. I generally have patients take their weekly rapamycin on a fasting or low-protein day. A large protein and carbohydrate meal spikes mTOR, which works directly against the drug. Dose it when you are already fasted and the two cleanup signals stack instead of canceling out. It is a small detail that makes a real difference.

‍

As I mentioned, there is no large human trial of fasting combined with rapamycin. The combination rests on mechanism and on what longevity physicians, myself included, see in practice. That is exactly why it belongs in a supervised setting and not a self-experiment ordered off the internet.

‍

Why this fits how I practice

‍

In the Vitality Architecture, the framework I built my practice around, both fasting and rapamycin live in the cleanup phase. Neither is ever used in a vacuum. They sit on top of a foundation of preserved muscle, adequate protein, resistance training, and real stress resilience. We clean with fasting and rapamycin, then we eat and train to build. The cycle is the point, not either half of it.

‍

That muscle point is not a throwaway. mTOR also builds muscle, so the goal is never to crush it permanently. It is to pulse it down on a schedule, clear the cellular garbage, and then let it come back up to do its job. This is why weekly dosing and smart timing matter so much, and why I will not put an aggressive mTOR inhibitor into someone who is frail, underweight, losing muscle, fighting an infection, or in the middle of a hard muscle-building phase. The same caution applies to fasting. These are tools for the person stuck in growth mode, not for the person whose tank is already empty.

‍

How I actually use it

‍

Fasting usually starts simple. A consistent daily eating window and a longer overnight gap, with occasional deeper fasts layered in depending on the person. Rapamycin, when it is appropriate, is a low weekly pulsed dose, started conservatively, titrated slowly, timed around fasting and away from heavy training, and tracked with labs along the way. It is a prescription, it is off-label for this use, and it requires a physician who is actually paying attention. There is no universal dose and no universal protocol. The right plan for a man in his forties with stuck insulin and visceral fat is not the right plan for a lean, high-stress woman whose thyroid is already struggling. The skill is in the dosing, the timing, and knowing when not to use either one.

‍

Fasting and rapamycin are not magic and they are not suffering. They are two ways of giving your cells the one instruction modern life almost never sends: stop building for a while and start repairing. Used together, on a schedule, on top of protected muscle, they do that more completely than either does alone. Used carelessly, they strip the very reserve you are trying to protect. The difference is supervision, timing, and individualization, and that difference is the entire job.

‍

If you want to know whether fasting, rapamycin, or both belong in your protocol, and how they would actually be dosed and timed for your physiology, that is a conversation I am glad to have.

‍

Dr. Sheep

outliveconciergemedicine.com

drsheep@outliveconciergemedicine.com

References:

Di Francesco A, et al. Dietary restriction impacts health and lifespan of genetically diverse mice. Nature. 2024;634(8034):684-692.

Moel M, Harinath G, Lee V, et al. Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging (Albany NY). 2025.

‍